Annual EBITDA:
$158.83M-$4.32M(-2.65%)Summary
- As of today, GDRX annual EBITDA is $158.83 million, with the most recent change of -$4.32 million (-2.65%) on December 31, 2024.
- During the last 3 years, GDRX annual EBITDA has risen by +$93.48 million (+143.06%).
- GDRX annual EBITDA is now -2.65% below its all-time high of $163.15 million, reached on December 31, 2023.
Performance
GDRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$47.85M+$414.00K(+0.87%)Summary
- As of today, GDRX quarterly EBITDA is $47.85 million, with the most recent change of +$414.00 thousand (+0.87%) on September 30, 2025.
- Over the past year, GDRX quarterly EBITDA has increased by +$9.85 million (+25.91%).
- GDRX quarterly EBITDA is now -4.19% below its all-time high of $49.95 million, reached on March 31, 2025.
Performance
GDRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$191.12M+$9.85M(+5.43%)Summary
- As of today, GDRX TTM EBITDA is $191.12 million, with the most recent change of +$9.85 million (+5.43%) on September 30, 2025.
- Over the past year, GDRX TTM EBITDA has increased by +$49.92 million (+35.35%).
- GDRX TTM EBITDA is now at all-time high.
Performance
GDRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GDRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -2.6% | +25.9% | +35.4% |
| 3Y3 Years | +143.1% | +169.6% | +102.4% |
| 5Y5 Years | +0.8% | +190.6% | +129.8% |
GDRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -2.6% | +143.1% | -4.2% | +169.6% | at high | +138.8% |
| 5Y | 5-Year | -2.6% | +165.0% | -4.2% | +116.5% | at high | +158.6% |
| All-Time | All-Time | -2.6% | +165.0% | -4.2% | +116.5% | at high | +158.6% |
GDRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $47.85M(+0.9%) | $191.12M(+5.4%) |
| Jun 2025 | - | $47.44M(-5.0%) | $181.27M(+5.7%) |
| Mar 2025 | - | $49.95M(+8.9%) | $171.42M(+8.6%) |
| Dec 2024 | $158.83M(-2.6%) | $45.88M(+20.7%) | $157.84M(+11.8%) |
| Sep 2024 | - | $38.01M(+1.1%) | $141.20M(+14.2%) |
| Jun 2024 | - | $37.58M(+3.3%) | $123.64M(+1.5%) |
| Mar 2024 | - | $36.37M(+24.4%) | $121.86M(+7.1%) |
| Dec 2023 | $163.15M(+72.3%) | $29.24M(+43.0%) | $113.83M(+8.0%) |
| Sep 2023 | - | $20.45M(-42.9%) | $105.41M(+2.6%) |
| Jun 2023 | - | $35.80M(+26.3%) | $102.70M(+28.3%) |
| Mar 2023 | - | $28.34M(+36.2%) | $80.03M(-6.6%) |
| Dec 2022 | $94.69M(+44.9%) | $20.82M(+17.3%) | $85.65M(-9.3%) |
| Sep 2022 | - | $17.75M(+35.2%) | $94.41M(-1.9%) |
| Jun 2022 | - | $13.13M(-61.3%) | $96.19M(+1.2%) |
| Mar 2022 | - | $33.96M(+14.9%) | $95.03M(+45.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $65.34M(+126.7%) | $29.57M(+51.4%) | $65.34M(+125.8%) |
| Sep 2021 | - | $19.53M(+63.3%) | -$253.61M(+22.2%) |
| Jun 2021 | - | $11.96M(+179.2%) | -$325.99M(-12.1%) |
| Mar 2021 | - | $4.28M(+101.5%) | -$290.91M(-17.9%) |
| Dec 2020 | -$244.48M(-255.2%) | -$289.39M(-447.6%) | -$246.72M(-396.7%) |
| Sep 2020 | - | -$52.84M(-212.3%) | $83.17M(-53.3%) |
| Jun 2020 | - | $47.04M(-3.0%) | $178.15M(+3.1%) |
| Mar 2020 | - | $48.48M(+19.7%) | $172.72M(+11.1%) |
| Dec 2019 | $157.57M(+81.0%) | $40.50M(-3.9%) | $155.42M(+35.2%) |
| Sep 2019 | - | $42.14M(+1.3%) | $114.92M(+57.9%) |
| Jun 2019 | - | $41.61M(+33.4%) | $72.78M(+133.4%) |
| Mar 2019 | - | $31.18M | $31.18M |
| Dec 2018 | $87.07M(+46.6%) | - | - |
| Dec 2017 | $59.41M(+112.1%) | - | - |
| Dec 2016 | $28.01M | - | - |
FAQ
- What is GoodRx Holdings, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. annual EBITDA year-on-year change?
- What is GoodRx Holdings, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. quarterly EBITDA year-on-year change?
- What is GoodRx Holdings, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. TTM EBITDA year-on-year change?
What is GoodRx Holdings, Inc. annual EBITDA?
The current annual EBITDA of GDRX is $158.83M
What is the all-time high annual EBITDA for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high annual EBITDA is $163.15M
What is GoodRx Holdings, Inc. annual EBITDA year-on-year change?
Over the past year, GDRX annual EBITDA has changed by -$4.32M (-2.65%)
What is GoodRx Holdings, Inc. quarterly EBITDA?
The current quarterly EBITDA of GDRX is $47.85M
What is the all-time high quarterly EBITDA for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high quarterly EBITDA is $49.95M
What is GoodRx Holdings, Inc. quarterly EBITDA year-on-year change?
Over the past year, GDRX quarterly EBITDA has changed by +$9.85M (+25.91%)
What is GoodRx Holdings, Inc. TTM EBITDA?
The current TTM EBITDA of GDRX is $191.12M
What is the all-time high TTM EBITDA for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high TTM EBITDA is $191.12M
What is GoodRx Holdings, Inc. TTM EBITDA year-on-year change?
Over the past year, GDRX TTM EBITDA has changed by +$49.92M (+35.35%)